The largest database of trusted experimental protocols

Bromodeoxyuridine (brdu)

Manufactured by Merck Group
Sourced in United States, Germany, United Kingdom, France, Spain, China, Sao Tome and Principe, Switzerland, Macao, Australia, Canada, Belgium, Japan, Israel, Poland

BrdU is a synthetic nucleoside that is an analog of the DNA base thymidine. It can be incorporated into the newly synthesized DNA of replicating cells, substituting for thymidine during the DNA synthesis phase of the cell cycle.

Automatically generated - may contain errors

2 228 protocols using bromodeoxyuridine (brdu)

1

Continuous BrdU Labeling of Lymphoid Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For continuous BrdU labeling, groups of 3–4 mice were initially injected intraperitoneally with 0.1 mg bromodeoxyuridine (BrdU) (Sigma, St Louis, MO) in saline and then continuously given BrdU (0.8 mg/mL) in drinking water. After various times, lymphoid organs were harvested and cell suspensions prepared.
BrdU staining was then performed with BD BrdU staining kit following the manufacturer’s instruction.
+ Open protocol
+ Expand
2

Tracking Neutrophil Progenitor Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To label proliferating neutrophil progenitors in the BM, mice were injected i.p. with 1-mg BrdU (Sigma-Aldrich) on day +18 after SCT, and emergence of BrdU+ neutrophils in the peripheral blood was tracked sequentially after BrdU injection. To stain BrdU in the cells, cells were fixed and permeabilized with the transcription factor staining buffer set (eBiosciences, San Diego, CA), treated with 0.3 mg/ml DNaseI (Sigma-Aldrich), and stained with anti-BrdU mAbs. Dead cells were excluded from analyses using Live/Dead Fixable Viability Dye eFluor 450 (eBioscience).
+ Open protocol
+ Expand
3

Keratinocyte Cell Cycle Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Keratinocytes were harvested, fixed and stained for BrdU, DNA content (Propidium Iodide, PI), γH2AX, involucrin and keratins K16, K1 as previously described11 (link),12 (link). Keratin K13 was labelled as K1. All antibody stainings were controlled by the use of similar concentration of isotype negative antibody (mouse IgG, Sigma-Aldrich; rabbit serum, or anti-BrdU in non-BrdU containing cells). After staining, cells were firmly resuspended and filtered through a 70 µM mesh to minimise the presence of aggregates and then analysed on a Becton Dickinson FACS Canto™ and CytoFLEX (Beckman Coulter). 10,000 events were gated and acquired. For DNA synthesis analyses, cells were cultured in the presence of 10 μM BrdU (Sigma-Aldrich) for 1.5 h and harvested. For BrdU pulse-chase experiment, cells were cultured for 1.5 h in the presence of 10 μM BrdU just before irradiation (Sigma-Aldrich) and were harvested 48 or 72 h after irradiation. BrdU staining and DNA content analysis with PI (25 μg/ml, 12 h) were performed as described11 (link).
+ Open protocol
+ Expand
4

Investigating Exercise-Induced Neurogenesis in Aged Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine stem and progenitor cell populations, 1-year-old p16Ink4a WT and KO mice were exposed to running wheels for 12 days and sacrificed 0, 16, and 28 days after the end of the exercise session together with sedentary mice (Figures 1A, 2A, 4A).
In 1-year-old p16Ink4a WT and KO mice, 1- to 5-day-old progenitor cells and neurons were detected by bromodeoxyuridine (BrdU) incorporation, after treatment with five daily injections of BrdU (95 mg/kg i.p.; Sigma Aldrich, St Louis, MO, USA), performed during the last days of running (i.e., running was until day 12, and BrdU injection were from day 7 to day 11; Figure 3B).
The terminally differentiated neurons (28-day-old) were detected 28 days after the end of the 12 days running sessions, following treatment with five daily injections of BrdU (95 mg/kg i.p.) during the last days of exercise (Figure 3F).
Brains were collected after transcardiac perfusion with 4% paraformaldehyde (PFA) in PBS and kept overnight in PFA. Brains were then equilibrated in 30% sucrose and cryopreserved at −80°C.
+ Open protocol
+ Expand
5

Brdu Labeling for Cardiac Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
NRCMs were cultured in a medium containing 10 μM BrdU (Sigma-Aldrich, St. Louis, MO, United States) a day before OGD or normal culture, followed by another 6-h incubation with BrdU. In the adult heart section BrdU assay, BrdU at 500 μg/mL (Sigma-Aldrich) was administered to each rat via intraperitoneal injection twice a day after surgery for a 7-day period.
+ Open protocol
+ Expand
6

Bromodeoxyuridine Injection for Cellular Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bromodeoxyuridine (BrdU) (Sigma-Aldrich) was injected 8 days before the enrichment period (50 mg kg-1 in saline, 3x at 2-h intervals; i.p.)14 ,22 (link).
24, 34, 44, 54 and 64 days post BrdU injection, five mice were taken randomly from each experimental group for sacrifice and BrdU, IdU and CldU immunohistochemistries were carried on as described in SI Methods14 ,22 (link).
The method used for BrdU-, IdU- and CldU-positive cell counting is described in SI Methods14 ,28 (link). The mean positive cell density of each array was calculated and averaged within each experimental group. Between-groups comparisons of the mean cell density were performed by ANOVA followed by post hoc t-tests with Tukey corrections. Unilateral t-tests were performed for comparisons between two groups. The level of significance was set to 0.05.
+ Open protocol
+ Expand
7

Cell Proliferation Assay with MSI1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Approximately 5,000 cells were plated in 96-well plates with 200 μl medium per well. The cells were then transfected as indicated with sh-MSI1 (MSI1 suppression plasmid), negative control vector (pcDNA 3.1 or sh-Ctrl) or MSI1 overexpression plasmid (MSI1) for 48 h, after which time 2 μl CCK-8 solution (Biosharp) was added to each well and the cells were incubated for a further 4 h. The absorbance at 450 nm was measured using a micro-plate reader (Thermo Fisher Scientific, Inc.).
To detect BrdU incorporation, the cells transfected with the indicated plasmids were washed thoroughly with medium and then cultured in fresh medium containing 10 μM BrdU (Sigma-Aldrich; Merck KGaA) for 1 h. The cells were then allowed to grow in BrdU-free medium for another 48 h, after which time they were harvested for detection. The harvested cells were washed with PBS, fixed in 70% ice-cold ethanol, resuspended in 2N HCl and incubated for 30 min at room temperature, followed by hybridization with a mouse monoclonal anti-BrdU antibody (cat. no. ab8152, dilution, 1:500, Abcam) overnight at 4°C. Finally, the cells were rinsed with PBS combined with Tween-20 and incubated with fluorescein isothiocyanate-conjugated rabbit anti-mouse immunoglobulin antibody (Jackson ImmunoResearch), followed by staining with 4′,6-diamidino-2-phenylindole solution for 10 min prior to image capture.
+ Open protocol
+ Expand
8

Evaluating Post-Stroke Brain Damage

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 15 days following stroke, all animals were deeply anesthetized with an overdose of Avertin. Transcardial perfusion was performed using cold phosphate-buffered saline, followed by 4% paraformaldehyde. Brains were fixed overnight in PFA, transferred to 30% sucrose solution for cryoprotection for at least 24 h. Some brains were flash-frozen (n = 4–5/grp) for protein and RNA analysis, and these were not used for infarct quantification. Brains were cut into 30 μm sections using a microtome. Floating sections were stored at −20 °C until staining. For bromodeoxyuridine (BrdU) staining, a sub-cohort of mice (n = 4/grp) were injected with 75 mg/kg of BrdU (Sigma-Aldrich, St. Louis, MO, USA) once a day from days 3–7 after stroke to control for stress due to repeated handling and BrdU injections; all other mice received saline injections once a day. Eight sections at regular intervals from the appearance of the corpus callosum were mounted, stained with cresyl violet, and used for calculations of% total tissue loss compared to the contralateral hemisphere as described previously [62 (link)].
+ Open protocol
+ Expand
9

BrdU Incorporation Assay by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell cultures were pulse labeled with 50 μM BrdU (Sigma; 50mM stock prepared in ddH2O) for 30 min, and BrdU incorporated into chromosomal DNA was detected using an Alexa Fluor 488-conjugated anti-BrdU antibody by flow cytometry. Briefly, after labeling with BrdU, cell cultures were harvested, fixed in 70% Ethanol, and stored at –20°C. Following fixation, cells were pelleted, and chromosomal DNA was denatured for 30 min. at room temperature by resuspending cells in 2 ml of Denaturation Solution (2N HCl+0.5% Triton X-100). Post-denaturation, cells were pelleted, neutralized for 10 min at room temperature by resuspension in 2 ml of 0.1M Sodium tetraborate, re-pelleted and then washed once by resuspension in 1 ml of 1% BSA (Bovine Serum Albumin), 0.5% Tween-20 in PBS (Blocking Solution, BLS) before incubation of resuspended cells in 100 μl BLS 1 μg/ml α-BrdU Alexa Fluor 488 with gentle agitation for 2 hours at room temperature. Following the antibody binding step, cells were harvested by pelleting at 1000 rpm for 30 sec. at 4°C, washed three times by resuspension of cell pellets twice with 500 μl blocking buffer and once with PBS containing 0.1% triton-X 100, and then stained with PI staining solution as described above.
+ Open protocol
+ Expand
10

BrdU Incorporation Assay for Proliferating Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Detection of BrdU incorporation in DNA-synthesizing cells was performed by adding 10 mM of BrdU (Sigma) to the secondary sphere. After a 72-h incubation period, spheres were plated onto coverslips in a 24-well plate containing DMEM/F12 and 10% FBS. After 24 h of cell seeding, coverslips were fixed and incubated in 2N HCl for 30 min at 37°C. Immunodetection of BrdU was performed using a monoclonal antibody against BrdU (1 : 500; Sigma). Fluorescence TRITC-tagged secondary antibody (1 : 200) was employed for visualization.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!